Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Cirugia Y Cirujanos|November 18, 2003
[T lymphocyte immunotherapy in patients with cancer]Víctor M Valdespino-Gómez, Leticia Rocha-Zavaleta
Life Sciences|August 2, 2015
Erythropoietin protects neuroblastoma cells against etoposide and vincristine by activating ERK and AKT pathways but has no effect in kidney cellsMaria Jose Vazquez-Mellado, Cecilia Aguilar, Leticia Rocha-Zavaleta
Journal of Medical Virology|December 19, 2001
Parenteral and oral immunization with a plasmid DNA expressing the human papillomavirus 16-L1 gene induces systemic and mucosal antibodies and cytotoxic T lymphocyte responsesLeticia Rocha-Zavaleta, Jorge E Alejandre, Alejandro Garcia-Carranca
Molecular & Cellular Oncology|March 20, 2026
The LNK adaptor protein: a dual regulator of proliferation and migration in solid tumorsJessica C Mantilla-Ollarves, Laura Velazquez, Leticia Rocha-Zavaleta
FEMS Immunology and Medical Microbiology|December 17, 2009
Adjuvants in tuberculosis vaccine developmentSilvia A Moreno-Mendieta, Leticia Rocha-Zavaleta, Romina Rodriguez-Sanoja
Biomedical Reports|October 2, 2024
STAT3 and the STAT3‑regulated inhibitor of apoptosis protein survivin as potential therapeutic targets in colorectal cancer (Review)Liliana Cortés-Ballinas, Tania V López-Pérez, Leticia Rocha-Zavaleta
Vitamins and Hormones|June 21, 2017
Erythropoietin, Stem Cell Factor, and Cancer Cell MigrationMaria J Vazquez-Mellado, Victor Monjaras-Embriz, Leticia Rocha-Zavaleta
International Journal of Molecular Sciences|October 14, 2023
Modulation of JAK-STAT Signaling by LNK: A Forgotten Oncogenic Pathway in Hormone Receptor-Positive Breast CancerJosé A López-Mejía, Jessica C Mantilla-Ollarves, Leticia Rocha-Zavaleta
Cancer Investigation|February 20, 2014
IL-2 enhances cervical cancer cells proliferation and JAK3/STAT5 phosphorylation at low doses, while at high doses IL-2 has opposite effectsArturo Valle-Mendiola, Benny Weiss-Steider, Leticia Rocha-Zavaleta, et al.
Leukemia & Lymphoma|September 28, 2012
Hypoxia inducible factor-1α induces chemoresistance phenotype in non-Hodgkin lymphoma cell line via up-regulation of Bcl-xLMarco A Hernandez-Luna, Leticia Rocha-Zavaleta, Mario I Vega, et al.
Pageof 5